1 Min Read
Jan 2 (Reuters) - Promore Pharma Ab:
* WILL CONTINUE TO SEEK FUNDING FOR A PHASE III CLINICAL TRIAL ON PXL01 IN NORTH AMERICA Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.